July 18, 2025

Later Eating Linked to Insulin Resistance

A twin study found that individuals who consumed most of their daily calories later in their personal circadian rhythm had lower insulin sensitivity and greater insulin resistance, with genetics playing a role in meal timing behavior.

Conexiant

July 18, 2025

Blood Test Predicts Organ Aging and Mortality

Researchers used blood proteins to estimate the biological age of 11 organs in over 44,000 people, revealing that older brain and immune systems were linked to higher disease and death risks, while younger ones predicted longer life.

Conexiant

July 18, 2025

Can Use of Aprepitant During Chemotherapy Improve Triple-Negative Breast Cancer Outcomes?

A commonly used antiemetic may help to improve patient outcomes when given during chemotherapy treatment for women with early triple-negative breast cancer, study findings suggest.

The ASCO Post

July 18, 2025

Decade of Data Validates Life’s Simple 7

A decade-long review supports that higher Life’s Simple 7 cardiovascular health scores significantly reduce risks of chronic disease, mortality, and health care use.

Conexiant

July 17, 2025

Mount Sinai Study: Controlling Heart Rhythm Before m-TEER Improves Outcomes

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be rehospitalized for heart failure, compared to patients without AF. These are the findings from a Mount Sinai Fuster Heart Hospital study that links the presence of AF at the time of the procedure to worse outcomes following the procedure.

Mount Sinai New York

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant

July 17, 2025

Semaglutide, Tirzepatide Linked to Lower Dementia Risk

Researchers found that semaglutide and tirzepatide were associated with reduced risks of dementia, stroke, and all-cause mortality in patients with type 2 diabetes and obesity.

Conexiant

July 17, 2025

Hormone Therapy Type Tied to Diverging Risks of Breast Cancer Before Age 55

Researchers found that unopposed estrogen therapy was linked to reduced young-onset breast cancer risk, while estrogen plus progestin therapy increased risk in certain subgroups.

Conexiant

July 17, 2025

Medical Oddities: Plague, Still a Thing

Old threats, odd urges, crispy skin, toxic air, and tea with benefits—all in one go.

Conexiant